2032: President Xi of China mandates that all fetuses receive genetic augmentation, particularly for improvements in brain function. The potential return on investment is enormous — a procedure costing a few hundred dollars, for a genius who might produce ideas worth tens of millions. Elsewhere, regulators and ethicists bemoan the practice, and the vox populi calls for a ban. In two decades, that difference is worth tens of trillions of dollars per year, and cements China as the pre-eminent research hub, with the most advanced industries. Good luck, Revert.